stuartlpbi | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

About: Stuart Cantor

Website: http://stuartlpbi.wordpress.com
Details: I have a Ph.D. in pharmaceutical sciences and my expertise is in solid oral dosage formulation development and controlled-release technologies. I also have a deep background in intellectual property in the areas of chemistry, pharma, medical device, and biotech.

Posts by Stuart Cantor:

February 8, 2016 Bio-MEMS Technologies: Devices, Tissue Engineering & Drug Delivery, Presentation by Stuart Cantor, Ph.D. on 2/4/16

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,555 other followers
Recent Posts
- AACR and Dr. Margaret Foti Announce Free Virtual Annual Meeting for April 27, 28 2020 and other Free Resources March 31, 2020
- Live Notes from Town Hall for Patients with Leading Oncologists on Lung Cancer and COVID19 3_28_20 March 28, 2020
- From @Harvardmed Center for Bioethics: The Medical Ethics of the Corona Virus Crisis March 27, 2020
- Live Notes from @HarvardMed Bioethics: Authors Jerome Groopman, MD & Pamela Hartzband, MD, discuss Your Medical Mind March 27, 2020
- Glycobiology vs Proteomics: Glycobiologists Prespective in the effort to explain the origin, etiology and potential therapeutics for the Coronavirus Pandemic (COVID-19) March 26, 2020
- US Responses to Coronavirus Outbreak Expose Many Flaws in Our Medical System March 25, 2020
- How is the 3D Printing Community Responding to COVID-19? March 23, 2020
- Promise of Synthetic Biology for Covid-19 Vaccine March 23, 2020
- The Relevance of Glycans in the Viral Pathology of COVID-19 March 23, 2020
- Lesson 7 of Cell Signaling 7 Motility: Tubulin and Tutorial Quizes for #TUBiol3373 March 23, 2020
Archives
Archives
Categories
Categories
Meta